STAT6 and solitary fibrous tumor: Recently a NAB2-signal transducer and activator of transcription 6 (STAT6) gene fusion was discovered as a genetic hallmark of SFT, assessed by immunohistochemistry [62], facilitating the diagnosis, that until then was based on morphology, CD34, and Bcl-2 expression.